Status:
COMPLETED
Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Lung Transplant Infection
Fungal Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a single center, observational study of posaconazole PK sampling in lung transplant recipients. The patients enrolled will have up to 6 (3ml) pk samples (a total of 18 ml) and one 10ml blood s...
Detailed Description
PK blood samples will be obtained around a clinical dosing of posaconazole
Eligibility Criteria
Inclusion
- 18 years of age and older receiving posaconazole post transplant as part of their care received a lung transplant
Exclusion
- must meet inclusion criteria
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01419678
Start Date
October 1 2011
End Date
December 1 2014
Last Update
December 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213